REGENXBIO's Nina Hunter, Ph.D. Details The Accelerated Approval Pathway For Gene Therapies
Source: Cell & Gene
REGENXBIO's VP of Regulatory and Science Policy, Nina Hunter, Ph.D., shares potential solutions to gene therapies' regulatory roadblocks and why the accelerated approval pathway is so pertinent.
